CIK 0000874716 · Large accelerated filer
IDEXX LABORATORIES INC /DE
Sign in to watch- Ticker
- IDXX
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 010393723
- Phone
- 2075560300
- Business address
- ONE IDEXX DRIVE, WESTBROOK, ME, 04092-2041
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $28,567,935
- in 5 filings
Net −$28,567,935. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- MAZELSKY JONATHAN JAY −$17.7M Executive Chair of the Board sold 23% of stake
- Underberg Sharon E. −$6.1M EVP, GC & Corporate Secretary sold 55% of stake
- Lane Michael −$2.7M Executive Vice President sold 49% of stake
- Kingsley Lawrence D −$1.2M Director sold 19% of stake
- JUNIUS DANIEL M −$845K Director sold 34% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-04 | MAZELSKY JONATHAN JAY Executive Chair of the Board | Sale | −1,840 | $707.84 | $1.3M | 87,710.3 |
| 2026-11-04 | MAZELSKY JONATHAN JAY Executive Chair of the Board | Sale | −1,300 | $709.00 | $922K | 86,410.3 |
| 2026-11-04 | MAZELSKY JONATHAN JAY Executive Chair of the Board | Sale | −1,501 | $710.12 | $1.1M | 84,909.3 |
| 2026-11-04 | MAZELSKY JONATHAN JAY Executive Chair of the Board | Sale | −775 | $711.31 | $551K | 84,134.3 |
| 2026-11-04 | MAZELSKY JONATHAN JAY Executive Chair of the Board | Sale | −331 | $711.95 | $236K | 83,803.3 |
| 2026-11-04 | MAZELSKY JONATHAN JAY Executive Chair of the Board | Option exercise · Non-Qualified Stock Option (right-to-buy) | −25,140 | 0 | ||
| 2026-11-04 | Lane Michael Executive Vice President | Sale | −242.94 | $687.85 | $167K | 7,812 |
| 2026-11-04 | Lane Michael Executive Vice President | Sale | −2,059 | $689.70 | $1.4M | 5,753 |
| 2026-11-04 | Lane Michael Executive Vice President | Sale | −1,677 | $687.46 | $1.2M | 4,076 |
| 2026-11-04 | JUNIUS DANIEL M Director | Sale | −700 | $705.78 | $494K | 2,861 |
| 2026-11-04 | JUNIUS DANIEL M Director | Sale | −500 | $701.69 | $351K | 2,361 |
| 2026-10-30 | HOOLEY JOSEPH L Director | Grant or award | +48 | $551.21 | $26K | 373 |
| 2026-09-04 | Kingsley Lawrence D Director | Option exercise | +2,203 | $114.17 | $252K | 11,771 |
| 2026-09-04 | Kingsley Lawrence D Director | Sale | −2,203 | $532.08 | $1.2M | 9,568 |
| 2026-09-04 | Kingsley Lawrence D Director | Option exercise · Non-Qualified Stock Option (right-to-buy) | −2,203 | 0 | ||
| 2026-08-20 | Emerson Andrew EVP, CFO and Treasurer | Option exercise | +265 | $178.26 | $47K | 4,507.44 |
| 2026-08-20 | Emerson Andrew EVP, CFO and Treasurer | Shares withheld for taxes | −86 | 4,421.44 | ||
| 2026-08-20 | Emerson Andrew EVP, CFO and Treasurer | Option exercise · Incentive Stock Option (right-to-buy) | −265 | 925 | ||
| 2026-07-30 | HOOLEY JOSEPH L Director | Grant or award | +49 | $558.80 | $27K | 325 |
| 2026-06-01 | FENNELL GEORGE Executive Vice President | Option exercise | +639 | 10,717 |
Page 2 of 28 · 552 trades